Seeing Is Believing
Currently out of the existing stock ratings of Julian Harrison, 210 are a BUY (95.02%), 10 are a HOLD (4.52%), 1 are a SELL (0.45%).
Analyst Julian Harrison, currently employed at BTIG, carries an average stock price target met ratio of 33.3% that have a potential upside of 56.57% achieved within 144 days.
Julian Harrison’s has documented 428 price targets and ratings displayed on 34 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on CGEM, Cullinan Oncology LLC.
Analyst best performing recommendations are on AVTE (AEROVATE THERAPEUTICS).
The best stock recommendation documented was for AVTE (AEROVATE THERAPEUTICS) at 12/6/2022. The price target of $945 was fulfilled within 6 days with a profit of $330.1 (53.68%) receiving and performance score of 89.47.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Sep-2024
$160
$21.92 (15.87%)
$100
Buy Since 06-Sep-2016
$170
$31.92 (23.12%)
$117
1 months 22 days ago
(31-Aug-2026)
35/36 (97.22%)
$22.25 (15.06%)
283
Buy Since 17-Jun-2025
$182
$43.92 (31.81%)
$175
1 months 22 days ago
(31-Aug-2026)
4/6 (66.67%)
$34.25 (23.18%)
140
Buy Since 04-Dec-2024
$178
$39.92 (28.91%)
$153
2 months 6 days ago
(17-Aug-2026)
8/9 (88.89%)
$19.38 (12.22%)
95
Hold Since 02-Mar-2026
$186
$47.92 (34.70%)
$95
2 months 13 days ago
(10-Aug-2026)
1/2 (50%)
$36 (24.00%)
6
Which stock is Julian Harrison most bullish on?
Which stock is Julian Harrison most reserved on?
What Year was the first public recommendation made by Julian Harrison?